OLR1 Antikörper (N-Term) (Cy3)
Kurzübersicht für OLR1 Antikörper (N-Term) (Cy3) (ABIN8018789)
Target
Alle OLR1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Verwendungszweck
- Anti-LOX 1/OLR1 Antibody Cy3 Conjugated
-
Spezifität
- No cross reactivity with other proteins.
-
Kreuzreaktivität (Details)
- No cross-reactivity with other proteins
-
Aufreinigung
- Immunogen affinity purified.
-
Immunogen
- A synthetic peptide corresponding to a sequence at the N-terminus of human LOX 1.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Flow Cytometry, 1-3 μg/1x106 cells
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
Haltbarkeit
- 12 months
-
-
- OLR1 (Oxidized Low Density Lipoprotein (Lectin-Like) Receptor 1 (OLR1))
-
Andere Bezeichnung
- OLR1
-
Hintergrund
-
Background: OLR1 (oxidized low density lipoprotein (lectin-like) receptor 1) also called CLEC8A, LOX-1, SCARE1, is a receptor protein which belongs to the C-type lectin superfamily. The OLR1 gene encodes a cell-surface endocytosis receptor for oxidized low density lipoprotein (OxLDL). The OLR1 gene is mapped on 12p13.2. Incubation of the cells with LDL had no effect on LOX1 expression, but incubation with OxLDL resulted in a dose-dependent increase in LOX1 mRNA and protein expression; however, very high concentrations of OxLDL caused a decrease in OxLDL expression, perhaps indicating toxic effects on endothelial cells. LOX1 was also expressed in macrophages, but not in vascular smooth muscle cells. The findings suggested a role for LOX1 in the pathophysiology of atherosclerotic cardiovascular disease. LOX1 expression was detected in all choroidal neovascular membranes, regardless of structure, whereas there was no evidence of LOX1 within the posterior segments of normal eyes. LOX1 plays an active role in the pathogenesis of choroidal neovascularization, especially in ARMD.
Gene Full Name: oxidized low density lipoprotein receptor 1
Sequence Similarities: Contains 1 C-type lectin domain.
-
Gen-ID
- 4973
-
UniProt
- P78380
Target
-